sanofi, Covance in R&D deal

Covance Inc. (NYSE:CVD) gained $4.61 (11%) to $46.79 on Thursday after the CRO signed a 10-year R&D services agreement with sanofi-aventis Group (Euronext:SAN; NYSE:SNY) that could be worth up to $2.2...